Ownership Summary
Ascentage Pharma Group International (NASDAQ:AAPG) showed up in the 13F filings of 7 institutional investors as of March 2026.
- They owned 0.0% of outstanding stock in March 2026, down from 0.0% the prior quarter.
- They decreased total shares held in Ascentage Pharma Group International by -13.46% from last quarter, and the number of investors in AAPG stayed flat annually.
- Of these 7 holders, 3 added to their stakes in Ascentage Pharma Group International, 3 trimmed positions, and 1 made no changes.
- Combined, these investors held 30.29K shares in AAPG for March 2026, down by 4.71K shares quarter on quarter, and down 206.91K shares year over year.
- Point72 Asset Management, L.P. leads ownership in AAPG with 16.06K shares as of March 31, 2026, equal to 0.0% of outstanding shares.
- The largest buyers of Ascentage Pharma Group International for the quarter ending March 2026 were Morgan Stanley (345), Tower Research Capital LLC (TRC) (288), EverSource Wealth Advisors, LLC (47).
- The biggest sellers of Ascentage Pharma Group International for the quarter ending March 2026 included UBS Group AG (4.11K), Point72 Asset Management, L.P. (670), XY Capital Ltd (614).
- Business Quant data shows the 7 biggest positions in Ascentage Pharma Group International as of March 2026 are held by Point72 Asset Management, L.P. (16.06K), XY Capital Ltd (13.01K), Tower Research Capital LLC (TRC) (518), Morgan Stanley (498), UBS Group AG (124), EverSource Wealth Advisors, LLC (71), Royal Bank Of Canada (6).